blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3722433

EP3722433 - PROMOTER AND REGULATORY ELEMENTS FOR IMPROVED EXPRESSION OF HETEROLOGOUS GENES IN HOST CELLS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.05.2024
Database last updated on 15.06.2024
FormerThe patent has been granted
Status updated on  23.06.2023
FormerGrant of patent is intended
Status updated on  16.02.2023
FormerRequest for examination was made
Status updated on  11.09.2020
Most recent event   Tooltip07.06.2024Lapse of the patent in a contracting state
New state(s): MC		published on 10.07.2024 [2024/28]
Applicant(s)For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, California 91320-1799 / US
[2020/42]
Inventor(s)01 / DARIS, Mark
1210 Rotella Street
Newbury Park, CA 91320 / US
02 / STEVENS, Jennitte LeAnn
126 Siesta Avenue
Thousand Oaks, CA 91360 / US
03 / LI, Chi-Ming Kevin
3001 Avenida de los Arboles
Thousand Oaks, CA 91362 / US
04 / GE, Huanying
104 Dumbledore Court
Cary, NC 27519 / US
 [2020/42]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2020/42]
Application number, filing date20173389.614.10.2015
[2020/42]
Priority number, dateUS201462064335P15.10.2014         Original published format: US 201462064335 P
[2020/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3722433
Date:14.10.2020
Language:EN
[2020/42]
Type: B1 Patent specification 
No.:EP3722433
Date:26.07.2023
Language:EN
[2023/30]
Search report(s)(Supplementary) European search report - dispatched on:EP19.08.2020
ClassificationIPC:C12N15/85
[2020/42]
CPC:
C12N15/85 (EP,US); C07K14/47 (US); C12N9/0008 (EP,US);
C12N9/88 (EP,US); C12Y102/01012 (EP,US); C12N2830/00 (EP,US);
C12N2830/15 (EP,US); C12N2830/34 (US); C12N2830/42 (EP,US);
C12N2830/85 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/42]
Extension statesBA07.05.2020
ME07.05.2020
TitleGerman:PROMOTOR UND REGULATORISCHE ELEMENTE ZUR VERBESSERTEN EXPRESSION VON HETEROLOGEN GENEN IN WIRTSZELLEN[2020/42]
English:PROMOTER AND REGULATORY ELEMENTS FOR IMPROVED EXPRESSION OF HETEROLOGOUS GENES IN HOST CELLS[2020/42]
French:PROMOTEUR ET ÉLÉMENTS RÉGULATEURS POUR AMÉLIORER L'EXPRESSION DE GÈNES HÉTÉROLOGUES DANS DES CELLULES HÔTES[2020/42]
Examination procedure07.05.2020Examination requested  [2020/42]
14.04.2021Amendment by applicant (claims and/or description)
17.02.2023Communication of intention to grant the patent
15.06.2023Fee for grant paid
15.06.2023Fee for publishing/printing paid
15.06.2023Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP15794369.7  / EP3207146
Opposition(s)29.04.2024No opposition filed within time limit [2024/27]
Fees paidRenewal fee
07.05.2020Renewal fee patent year 03
07.05.2020Renewal fee patent year 04
07.05.2020Renewal fee patent year 05
14.10.2020Renewal fee patent year 06
29.09.2021Renewal fee patent year 07
21.10.2022Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT26.07.2023
CZ26.07.2023
DK26.07.2023
EE26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
MC26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SK26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
[2024/28]
Former [2024/23]AT26.07.2023
CZ26.07.2023
DK26.07.2023
EE26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SK26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/22]AT26.07.2023
CZ26.07.2023
DK26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/20]AT26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RS26.07.2023
SE26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/10]AT26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RS26.07.2023
SE26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/09]AT26.07.2023
FI26.07.2023
LT26.07.2023
NL26.07.2023
SE26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
Former [2024/08]LT26.07.2023
NL26.07.2023
NO26.10.2023
GR27.10.2023
Former [2024/05]NL26.07.2023
Documents cited:Search[A]WO2006123097  (SEROLOGICALS INVEST COMPANY IN [US], et al) [A] 1-9 * Whole doc., in particular p.10, l.14-29; Fig.1; example 1 *;
 [A]WO2008085962  (MILLIPORE CORP [MA], et al) [A] 1-9 * Whole doc, in particular p.6 (para. [0019]), p.26 (para.[0064]), p.32 (para. [0076]); page 5 *;
 [A]WO2013084157  (GLENMARK PHARMACEUTICALS SA [CH]) [A] 1-9 * Whole doc., in particular Fig. 7, 8; p.5, l.16 - p.6, l.2 *;
 [A]  - WILLIAMS STEVEN ET AL, "CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells", BMC BIOTECHNOLOGY, BIOMED CENTRAL LTD. LONDON, GB, (20050603), vol. 5, no. 1, doi:10.1186/1472-6750-5-17, ISSN 1472-6750, page 17, XP021005966 [A] 1-9 * Fig.1, 3; Results and Discussion *

DOI:   http://dx.doi.org/10.1186/1472-6750-5-17
 [A]  - KWAKS TED H J ET AL, "Identification of anti-repressor elements that confer high and stable protein production in mammalian cells", NATURE BIOTECHNOLOGY, GALE GROUP INC., NEW YORK, US, (20030520), vol. 21, no. 5, doi:10.1038/NBT814, ISSN 1087-0156, pages 553 - 558, XP002246849 [A] 1-9 * Whole doc., in particular p.553, col.1, p.554, col.2 (2nd and 3rd full para.), Fig.2, discussion *

DOI:   http://dx.doi.org/10.1038/nbt814
 [A]  - VALERIE LE FOURN ET AL, "CHO cell engineering to prevent polypeptide aggregation and improve therapeutic protein secretion", METABOLIC ENGINEERING, US, (20140101), vol. 21, doi:10.1016/j.ymben.2012.12.003, ISSN 1096-7176, pages 91 - 102, XP055239340 [A] 1-9 * Whole doc., in particular section 2.1 *

DOI:   http://dx.doi.org/10.1016/j.ymben.2012.12.003
by applicantUS30985
 US4560655
 WO8700195
 US4657866
 US4767704
 WO9003430
 US4927762
 WO9110741
 WO9117271
 WO9201047
 EP0481790
 US5122469
 US5229275
 WO9402602
 US5302697
 US5545403
 US5545807
 WO9630498
 US5565332
 US5567610
 WO9633735
 US5573905
 US5589369
 US5591669
 US5633162
 WO9824893
 US5877293
 US5939598
 US6022952
 US6054287
 WO0024782
 US6210924
 US6331415
 US6335178
 US2002004215
 US2002199213
 US2003044772
 US2003092125
 US2003104400
 US2003190317
 US7029909
 WO2007045463
    - MARINO M H, Biopharm, (19890000), vol. 2, pages 18 - 33
    - GOEDDEL D V et al., Methods Enzymol, (19900000), vol. 185, pages 3 - 7
    - WURM FBERNARD A, Curr Opin Biotechnol, (19990000), vol. 10, pages 156 - 159
    - BAEUERLE PA et al., "BiTE: Teaching antibodies to engage T-cells for cancer therapy", Curr Opin Mol Ther., (20090000), vol. 11, no. 1, pages 22 - 30, XP009151509
    - GLEASON et al., "Bispecific and trispecific killer cell engagers directly activate human NK cells through CD 16 signaling and induce cytotoxicity and cytokine production", Mol. Cancer Ther., (20120000), vol. 11, no. 12, doi:10.1158/1535-7163.MCT-12-0692, pages 1 - 11, XP055461268

DOI:   http://dx.doi.org/10.1158/1535-7163.MCT-12-0692
    - RATHANASWAMI et al., "High affinity binding measurements of antibodies to cell-surface-expressed antigens", Analytical Biochemistry, (20080000), vol. 373, doi:10.1016/j.ab.2007.08.014, pages 52 - 60, XP022575079

DOI:   http://dx.doi.org/10.1016/j.ab.2007.08.014
    - BHATNAGAR et al., J. Med. Chem., (19960000), vol. 39, pages 3814 - 9
    - CUTHBERTSON et al., J. Med. Chem., (19970000), vol. 40, pages 2876 - 82
    - LOWMAN, Ann. Rev. Biophys. Biomol. Struct., (19970000), vol. 26, pages 401 - 24
    - MATHER et al., Annals N.Y Acad. Sci., (19820000), vol. 383, pages 44 - 68
    - MANIATIS et al., Science, (19870000), vol. 236, page 1237
    - VOSS et al., Trends Biochem. Sci., (19860000), vol. 11, page 287
    - MAGNUSSON et al., "Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations", Journal of Gene Medicine, (20110000), vol. 13, no. 7-8, doi:10.1002/jgm.1585, pages 382 - 391, XP055572288

DOI:   http://dx.doi.org/10.1002/jgm.1585
    - XU et al., "Optimization of transcriptional regulatory elements for constructing plasmid vectors", Gene, (20010000), vol. 272, no. 1-2, doi:10.1016/S0378-1119(01)00550-9, pages 149 - 156, XP008158418

DOI:   http://dx.doi.org/10.1016/S0378-1119(01)00550-9
    - LI et al., "The role of chromatin during transcription", Cell, (20070000), vol. 128, pages 707 - 719
    - PIKAART MJ, "Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators", Genes Dev., (19980000), vol. 12, pages 2852 - 62
    - OTTE AP, "Various expression-augmenting DNA elements benefit from STAR-Select, a nove high stringency selection system for protein expression", Biotechnol Prog., (20070000), vol. 23, no. 4, doi:10.1021/bp070107r, pages 801 - 7, XP002446534

DOI:   http://dx.doi.org/10.1021/bp070107r
    - FERRARI S et al., "Chromatin domains boundaries delimited by a histone binding protein in yeast", J. Biol Chem., (20010000), vol. 279, doi:10.1074/JBC.M410346200, pages 55520 - 30, XP002583631

DOI:   http://dx.doi.org/10.1074/JBC.M410346200
    - KELLUM R. et al., "A group of scs elements function as domain boundaries in an enhancer-blocking assay", Mol. Cell Biol., (19920000), vol. 12, pages 2424 - 31, XP002347866
    - CHUNG JH et al., "A 5' element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila", Cell, (19930000), vol. 74, doi:10.1016/0092-8674(93)80052-G, pages 505 - 14, XP002946965

DOI:   http://dx.doi.org/10.1016/0092-8674(93)80052-G
    - WILLIAMS S et al., "CpG Island fragments from HNRAP2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhance in mammalian cells", BMC Biotechnol., (20050000), vol. 5, doi:10.1186/1472-6750-5-17, page 17, XP021005966

DOI:   http://dx.doi.org/10.1186/1472-6750-5-17
    - GRAHAM et al., Virology, (19730000), vol. 52, page 456
    - GUSS et al., EMBO J., (19860000), vol. 5, pages 15671575 - 103
    - CHU et al., Gene, (19810000), vol. 13, page 197
    - ENGELS et al., Angew. Chem. Int. Ed. Engl., (19890000), vol. 28, pages 716 - 734
    - BRODEUR et al., Methods in Enzymology: Guide to Molecular Cloning Techniques, Academic Press, Inc., (19870000), vol. 152, pages 51 - 63
    - WELLS et al., Gene, (19850000), vol. 34, page 315
    - URLAB et al., Proc. Natl. Acad. Sci USA, (19800000), vol. 77, page 4216
    - GRAHAM et al., J. Gen. Viral., (19770000), vol. 36, page 59
    - KILPATRICK et al., Hybridoma, (19970000), vol. 16, pages 381 - 389
    - KOHLER et al., Nature, (19750000), vol. 256, page 495
    - KOZBOR, J. Immunol., (19840000), vol. 133, page 3001
    - BARNES et al., Anal. Biochem., (19800000), vol. 102, page 255
    - SAMBROOK et al., Molecular Cloning: A Laboratory Guide, Cold Spring Harbor Press, (19890000), vol. 1-3
    - SANGER, F. et al., Proc. Natl. Acad. Sci. USA, (19770000), vol. 74, pages 5463 - 5467
    - URLAUB et al., Proc. Natl. Acad. Sci. USA, (19800000), vol. 77, page 4216
    - GRAHAM et al., J. Gen Viral., (19770000), vol. 36, page 59
    - MATHER, Biol. Reprod., (19800000), vol. 23, pages 243 - 251
    - HAM et al., Meth. Enz., (19790000), vol. 58, page 44
    - LINDMARK et al., J. Immunol. Meth., (19830000), vol. 62, pages 1 - 13
    - MORRISON, S. L. et al., "Chimeric Human Antibody Molecules; Mouse Antigen Binding Domains with Human Constant Region Domains", Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, pages 6841 - 6855
    - BOULIANNE, G. L. et al., Nature, (19840000), vol. 312, pages 643 - 646
    - JONES et al., Nature, (19860000), vol. 321, page 522 525
    - MORRISON et al., Proc. Natl. Acad. Sci., U.S.A., (19840000), vol. 81, page 6851 6855
    - MORRISONOI, Adv. Immunol., (19880000), vol. 44, page 65 92
    - VERHOEYER et al., Science, (19880000), vol. 239, page 1534 1536
    - PADLAN, Molec. Immun., (19910000), vol. 28, page 489 498
    - PADLAN, Molec. Immunol., (19940000), vol. 31, no. 3, page 169 217
    - KETTLEBOROUGH, C.A. et al., Protein Eng., (19910000), vol. 4, no. 7, pages 773 83 - 83
    - CO, M. S. et al., J. Immunol., (19940000), vol. 152, pages 2968 - 2976
    - STUDNICKA et al., Protein Engineering, (19940000), vol. 7, pages 805 - 814
    - MENDEZ et al., Nat. Genet., (19970000), vol. 15, pages 146 - 156
    - JAKOBOVITS et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, page 2551
    - JAKOBOVITS et al., Nature, (19930000), vol. 362, pages 255 - 258
    - BRUGGERMANN et al., Year in Immuno., (19930000), vol. 7, page 33
    - CATONKOPROWSKI, Proc. Natl. Acad. Sci. USA, (19900000), vol. 87, pages 6450 - 6454
    - JESPERS, L. S. et al., BiolTechnology, (19940000), vol. 12, pages 899 - 903
    - HOOGENBOOM et al., J. Mol. Biol., (19910000), vol. 227, page 381
    - MARKS et al., J. Mol. Biol, (19910000), vol. 222, pages 581 - 597
    - CLACKSON, T.WELLS, J. A., TIBTECH, (19940000), vol. 12, pages 173 - 184
    - BURTON, D. R.BARBAS III, C. F., Adv. Immunol., (19940000), vol. 57, pages 191 - 280
    - WINTER, G. et al., Annu. Rev. Immunol., (19940000), vol. 12, pages 433 - 455
    - WATKINS, "Screening of Phage-Expressed Antibody Libraries by Capture Lift", Methods in Molecular Biology, Antibody Phage Display: Methods and Protocols, vol. 178, pages 187 - 193
    - "NCBI", Database accession no. NW 003613610.1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.